<DOC>
	<DOCNO>NCT02947620</DOCNO>
	<brief_summary>A Multi-center , Randomized , double-blind , active-controlled , phase 3 trial evaluate safety efficacy Metformin/Atorvastatin subject Type II Diabetes dyslipidemia .</brief_summary>
	<brief_title>A Multi-center , Randomized , Double-blind , Active-controlled , Phase 3 Clinical Trial Evaluate Safety Efficacy Metformin/Atorvastatin Combination Therapy Subjects With Type II Diabetes Dyslipidemia</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Subjects Dyslipidemia Type II Diabetes 19 year later , men woman age 80 Pregnant woman , nurse mother subject agree assign contraception study Subject type I Diabetes Subject hypertension control treatment ( blood pressure &gt; 180/110mmHg )</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>